Marco Candela

Prof. Marco Candela

Alma Mater Studiorum Università di Bologna, Bologna, Italy

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Current Biology
Verified
Journal Article
Closed access
EBElena Biagi
Elena Biagi
CFClaudio Franceschi
Claudio Franceschi
SRSimone Rampelli
Simone Rampelli
MSMarco Severgnini
Marco Severgnini
RORita Ostan
Rita Ostan
MCMarco Candela
Marco Candela

1 June 2015 in Current Biology
Verified
Journal Article
Closed access
SRSimone Rampelli
Simone Rampelli
SSStephanie L. Schnorr
Stephanie L. Schnorr
CCClarissa Consolandi
Clarissa Consolandi
STSilvia Turroni
Silvia Turroni
MSMarco Severgnini
Marco Severgnini
MCMarco Candela
Marco Candela

6 May 2016 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
MCMarco Candela
Marco Candela
EBElena Biagi
Elena Biagi
MSMatteo Soverini
Matteo Soverini
CCClarissa Consolandi
Clarissa Consolandi
SQSara Quercia
Sara Quercia
PBPatrizia Brigidi
Patrizia Brigidi
The gut microbiota exerts a role in type 2 diabetes (T2D), and deviations from a mutualistic ecosystem layout are considered a key environmental factor contributing to the disease. Thus, the possibility of improving metabolic control in T2D by correcting gut microbiome dysbioses through diet has been evaluated. Here, we explore the potential of two different energy-restricted dietary approaches – the fibre-rich macrobiotic Ma-Pi 2 diet or a control diet recommended by Italian professional societies for T2D treatment – to correct gut microbiota dysbioses in T2D patients. In a previous 21-d open-label MADIAB trial, fifty-six overweight T2D patients were randomised to the Ma-Pi 2 or the control diet. For the present study, stools were collected before and after intervention from a subset of forty MADIAB participants, allowing us to characterise the gut microbiota by 16S rRNA sequencing and imputed metagenomics. To highlight microbiota dysbioses in T2D, the gut microbiota of thirteen normal-weight healthy controls were characterised. According to our findings, both diets were effective in modulating gut microbiome dysbioses in T2D, resulting in an increase of the ecosystem diversity and supporting the recovery of a balanced community of health-promoting SCFA producers, such asFaecalibacterium,Roseburia,Lachnospira,BacteroidesandAkkermansia. The Ma-Pi 2 diet, but not the control diet, was also effective in counteracting the increase of possible pro-inflammatory groups, such asCollinsellaandStreptococcus, in the gut ecosystem, showing the potential to reverse pro-inflammatory dysbioses in T2D, and possibly explaining the greater efficacy in improving the metabolic control.

1 January 2014 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MCMarco Candela
Marco Candela
STSilvia Turroni
Silvia Turroni
EBElena Biagi
Elena Biagi
FCFranck Carbonero
Franck Carbonero
SRSimone Rampelli
Simone Rampelli
PBPatrizia Brigidi
Patrizia Brigidi
Structural changes in the gut microbial community have been shown to accompany the progressive development of colorectal cancer. In this review we discuss recent hypotheses on the mechanisms involved in the bacteria-mediated carcinogenesis, as well as the triggering factors favoring the shift of the gut microbiota from a mutualistic to a pro-carcinogenic configuration. The possible role of inflammation, bacterial toxins and toxic microbiota metabolites in colorectal cancer onset is specifically discussed. On the other hand, the strategic role of inflammation as the keystone factor in driving microbiota to become carcinogenic is suggested. As a common outcome of different environmental and endogenous triggers, such as diet, aging, pathogen infection or genetic predisposition, inflammation can compromise the microbiota-host mutualism, forcing the increase of pathobionts at the expense of health-promoting groups, and allowing the microbiota to acquire an overall pro-inflammatory configuration. Consolidating inflammation in the gut, and favoring the bloom of toxigenic bacterial drivers, these changes in the gut microbial ecosystem have been suggested as pivotal in promoting carcinogenesis. In this context, it will become of primary importance to implement dietary or probiotics-based interventions aimed at preserving the microbiota-host mutualism along aging, counteracting deviations that favor a pro-carcinogenic microbiota asset.

1 August 2012 in Trends in Microbiology
Verified
Journal Article
Closed access
MCMarco Candela
Marco Candela
EBElena Biagi
Elena Biagi
SMSimone Maccaferri
Simone Maccaferri
STSilvia Turroni
Silvia Turroni
PBPatrizia Brigidi
Patrizia Brigidi

1 January 2012 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
MCMarco Candela
Marco Candela
SRSimone Rampelli
Simone Rampelli
Silvia TurroniSilvia Turroni
Silvia Turroni
MSMarco Severgnini
Marco Severgnini
CCClarissa Consolandi
Clarissa Consolandi
PBPatrizia Brigidi
Patrizia Brigidi
Playing a strategic role in the host immune function, the intestinal microbiota has been recently hypothesized to be involved in the etiology of atopy. In order to investigate the gastrointestinal microbial ecology of atopic disease, here we performed a pilot comparative molecular analysis of the faecal microbiota in atopic children and healthy controls.